OBJECTIVE
The main objective of this study was to investigate thermosensitive Pluronic F-127 (PF-127) hydrogel for the modified release of a potent alcohol and opioid antagonist, naltrexone (NTX) hydrochloride, in a subcutaneous injectable dosage form.
METHODS
The NTX hydrogels were prepared by the cold method, and the in vitro release profiles of various formulations were evaluated at 37°C u...